FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

ValueSets

28,933 resources

Source: Text:

By Version

By Authority

By Realm

 

Start Prev Rows 6400 - 6600 Next

PackageVersionIdentityName/TitleStatusFMMWGDateRealmAuthSource(s)
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1259Substance Use Disorder Short Acting Medicationactive2024-01ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1260Viloxazineactive2025-01ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1266Diabetic Retinopathy Severity Levelactive2025-01ushl7loinc
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1272Diabetesactive2025-01ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1273Diabetesactive2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.195.11.1003Counseling for Nutritionactive2017-05ushl7cpt
us.nlm.vsacR42.16.840.1.113883.3.464.1003.195.11.1004Counseling for Nutritionactive2023-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.195.12.1003Counseling for Nutritionactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1001Antibiotic Medications for Pharyngitisactive2025-01ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1078Nifedipine Medicationsactive2022-01ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1080Contraceptive Medicationsactive2025-01ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1109Meperidine Medicationsactive2024-01ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1129Desiccated Thyroid Medicationsactive2021-02ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1143Isotretinoinactive2022-01ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1167Dipyridamole Medicationsactive2021-02ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1205Leucovorinactive2023-07ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1211Aspirin and Other Antiplateletsactive2024-06ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1212DTaP Vaccineactive2024-11ushl7cvx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1214Hepatitis A Vaccineactive2018-03ushl7cvx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1216Hepatitis B Vaccineactive2025-04ushl7cvx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1220Child Influenza Vaccineactive2022-02ushl7cvx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1222Inactivated Polio Vaccine (IPV)active2021-09ushl7cvx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1228Pneumococcal Conjugate Vaccineactive2023-11ushl7cvx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1232Rotavirus Vaccine (3 dose schedule)active2018-03ushl7cvx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1234Varicella Zoster Vaccine (VZV)active2017-05ushl7cvx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1235Measles, Mumps and Rubella (MMR) Vaccineactive2017-05ushl7cvx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1252Guanfacine Medicationsactive2024-01ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1255Megestrol Medicationsactive2021-02ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1256Meprobamate Medicationsactive2021-02ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1266Aromatase Inhibitorsactive2024-01ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1267Glucocorticoids (oral only)active2024-02ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1481Potentially Harmful Nonbenzodiazepine Hypnotics for Older Adultsactive2024-01ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1482Potentially Harmful Antiinfectives for Older Adultsactive2025-01ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1517Dementia Medicationsactive2025-01ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1530Antidepressant Medicationactive2024-02ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1532Potentially Harmful Antipsychotics for Older Adultsactive2025-01ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.12.1001Antibiotic Medications for Pharyngitisactive2017-05ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.12.1080Contraceptive Medicationsactive2017-05ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.12.1143Isotretinoinactive2017-05ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.12.1170Varicella Zoster Vaccine (VZV)active2017-05ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.12.1205Leucovorinactive2017-05ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.12.1211Aspirin and Other Antiplateletsactive2024-06ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.12.1213Antidepressant Medicationactive2021-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.12.1214DTaP Vaccineactive2017-05ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.12.1215Hepatitis A Vaccineactive2017-05ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.12.1216Hepatitis B Vaccineactive2017-05ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.12.1218Child Influenza Vaccineactive2017-05ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.12.1219Inactivated Polio Vaccine (IPV)active2017-05ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.12.1221Pneumococcal Conjugate Vaccineactive2017-05ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.12.1223Rotavirus Vaccine (3 dose schedule)active2017-05ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.12.1224Measles, Mumps and Rubella (MMR) Vaccineactive2017-05ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.12.1265Aromatase Inhibitorsactive2018-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.12.1266Glucocorticoids (oral only)active2018-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.12.1480Potentially Harmful Nonbenzodiazepine Hypnotics for Older Adultsactive2017-05ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.12.1481Potentially Harmful Antiinfectives for Older Adultsactive2017-05ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.12.1510Dementia Medicationsactive2019-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.12.1522Potentially Harmful Benzodiazepines for Older Adultsactive2022-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.12.1523Potentially Harmful Antipsychotics for Older Adultsactive2022-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.11.1005Bilateral Mastectomyactive2024-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.11.1009Primary THA Procedureactive2023-07ushl7cpt
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.11.1015Flexible Sigmoidoscopyactive2023-02ushl7cpt
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.11.1016Flexible Sigmoidoscopyactive2017-12ushl7cms
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.11.1017Flexible Sigmoidoscopyactive2024-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.11.1020Fecal Occult Blood Test (FOBT)active2017-12ushl7loinc
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.11.1023Group A Streptococcus Testactive2024-11ushl7loinc
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.11.1024HbA1c Laboratory Testactive2023-02ushl7loinc
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.11.1026Hysterectomy with No Residual Cervixactive2023-02ushl7cpt
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.11.1027Hysterectomy with No Residual Cervixactive2024-11ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.11.1035Total Colectomyactive2024-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.11.1036Total Colectomyactive2021-02ushl7cpt
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.11.1055XRay Studyactive2022-02ushl7loinc
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.11.1061Gastric Bypass Surgeryactive2020-03ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.11.1062Gastric Bypass Surgeryactive2018-03ushl7cpt
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.11.1080Primary THA Procedureactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.11.1084History of bilateral mastectomyactive2017-12ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.11.1085History of bilateral mastectomyactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.11.1086Status Post Left Mastectomyactive2018-03ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.11.1087Status Post Right Mastectomyactive2018-03ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.11.1089Unilateral Mastectomy, Unspecified Lateralityactive2017-12ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.11.1090Unilateral Mastectomy, Unspecified Lateralityactive2017-12ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.11.1091Status Post Left Mastectomyactive2017-12ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.11.1092Status Post Right Mastectomyactive2017-12ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.11.1096Major Transplantactive2021-09ushl7cpt
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.11.1097Major Transplantactive2021-08ushl7cms
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.11.1132Unilateral Mastectomy Leftactive2021-10ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.11.1133Unilateral Mastectomy Rightactive2021-10ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.11.1134Hysterectomy with No Residual Cervixactive2023-09ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.11.1135Hysterectomy with No Residual Cervixactive2020-03ushl7cms
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.11.1140Bilateral Mastectomyactive2019-03ushl7cms
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.11.1143Total Colectomyactive2019-03ushl7cms
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.11.1144Unilateral Mastectomy Leftactive2019-03ushl7cms
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.11.1145Unilateral Mastectomy Rightactive2019-03ushl7cms
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.11.1148Palliative Interventionactive2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.12.1005Bilateral Mastectomyactive2024-01ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.12.1006Primary THA Procedureactive2023-08ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.12.1010Flexible Sigmoidoscopyactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.12.1011Fecal Occult Blood Test (FOBT)active2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.12.1012Group A Streptococcus Testactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.12.1013HbA1c Laboratory Testactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.12.1014Hysterectomy with No Residual Cervixactive2024-01ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.12.1019Total Colectomyactive2024-01ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.12.1034XRay Studyactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.12.1050Gastric Bypass Surgeryactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.12.1068History of bilateral mastectomyactive2017-12ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.12.1069Status Post Left Mastectomyactive2017-12ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.12.1070Status Post Right Mastectomyactive2017-12ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.12.1071Unilateral Mastectomy, Unspecified Lateralityactive2024-01ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.12.1075Major Transplantactive2024-01ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.12.1133Unilateral Mastectomy Leftactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.12.1134Unilateral Mastectomy Rightactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.198.12.1135Palliative Care Interventionactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.199.11.1064Anaphylactic Reaction to DTaP Vaccineactive2022-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.199.11.1100Malabsorption Syndromesactive2023-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.199.11.1102Malabsorption Syndromesactive2022-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.199.11.1105Intussusceptionactive2017-05ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.199.11.1106Intussusceptionactive2021-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.199.11.1107Influenza Virus LAIV Vaccineactive2021-02ushl7cvx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.199.11.1108Influenza Virus LAIV Vaccine Administeredactive2021-02ushl7cpt
us.nlm.vsacR42.16.840.1.113883.3.464.1003.199.12.1031Anaphylactic Reaction to DTaP Vaccineactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.199.12.1050Malabsorption Syndromesactive2024-01ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.199.12.1056Intussusceptionactive2017-05ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1004.2446Lower Extremity Visual Inspection Testactive2023-07ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1004.2447Pedal Pulse Result or Findingactive2023-07ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1004.2448Monofilament Test Result or Findingactive2023-07ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1004.2449Monofilament Testsactive2023-07ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1004.2450Lower Extremity Neurological Assessment Result or Findingactive2023-07ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1004.2451Lower Extremity Neurological Testsactive2023-07ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1004.2452Lower Extremity Visual Inspection Result or Findingactive2023-07ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1004.2616Autonomous Eye Exam Result or Findingactive2025-01ushl7loinc
us.nlm.vsacR42.16.840.1.113883.3.526.1577Pharmacologic Therapy for Hypertensionactive2021-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.2.1036Chronic Kidney Disease, Stage 5active2017-05ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1037Chronic Kidney Disease, Stage 5active2017-05ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1049Patient Provider Interactionactive2020-03ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1058Psych Visit for Family Psychotherapyactive2017-05ushl7cpt
us.nlm.vsacR42.16.840.1.113883.3.526.2.1063Occupational Therapy Evaluationactive2017-08ushl7cpt
us.nlm.vsacR42.16.840.1.113883.3.526.2.1067Dementia and Mental Degenerationsactive2024-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1068Dementia and Mental Degenerationsactive2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1069Standardized Tools for Assessment of Cognitionactive2017-05ushl7loinc
us.nlm.vsacR42.16.840.1.113883.3.526.2.1071Radiation Treatment Managementactive2017-08ushl7cpt
us.nlm.vsacR42.16.840.1.113883.3.526.2.1072Radiation Treatment Managementactive2017-05ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1073Standardized Pain Assessment Toolactive2017-05ushl7loinc
us.nlm.vsacR42.16.840.1.113883.3.526.2.1078Canceractive2025-01ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1079Canceractive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1080Chemotherapy Administrationactive2024-01ushl7cpt
us.nlm.vsacR42.16.840.1.113883.3.526.2.1081Chemotherapy Administrationactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.111Ophthalmological Servicesactive2021-02ushl7cpt
us.nlm.vsacR42.16.840.1.113883.3.526.2.113Prostate Cancer Treatmentactive2025-02ushl7cpt
us.nlm.vsacR42.16.840.1.113883.3.526.2.118Initial Myocardial Infarctionactive2020-03ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.119Initial Myocardial Infarctionactive2024-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.120Coronary Artery Disease No MIactive2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1238Ejection Fractionactive2025-01ushl7loinc
us.nlm.vsacR42.16.840.1.113883.3.526.2.1243Psychoanalysisactive2017-05ushl7cpt
us.nlm.vsacR42.16.840.1.113883.3.526.2.1244Renal Failure Due to ACE Inhibitoractive2024-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1251Group Psychotherapyactive2017-05ushl7cpt
us.nlm.vsacR42.16.840.1.113883.3.526.2.1256Allergy to ACE Inhibitor or ARBactive2024-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1257Intolerance to ACE Inhibitor or ARBactive2024-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.133Beta Blocker Therapyactive2023-02ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.526.2.1333Allergy to Beta Blocker Therapyactive2019-03ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1334Intolerance to Beta Blocker Therapyactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1341Heart Rateactive2024-02ushl7loinc
us.nlm.vsacR42.16.840.1.113883.3.526.2.1342Beta Blocker Therapy for LVSDactive2022-02ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.526.2.1344Acute and Subacute Iridocyclitisactive2025-01ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1353Limited Life Expectancyactive2025-04ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1363Annual Wellness Visitactive2023-12ushl7cms
us.nlm.vsacR42.16.840.1.113883.3.526.2.1364Macular Examactive2021-02ushl7loinc
us.nlm.vsacR42.16.840.1.113883.3.526.2.1372Tobacco Use Screeningactive2017-05ushl7loinc
us.nlm.vsacR42.16.840.1.113883.3.526.2.1374Bone Scanactive2018-07ushl7loinc
us.nlm.vsacR42.16.840.1.113883.3.526.2.1377Level of Severity of Retinopathy Findingsactive2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1381Macular Edema Findings Presentactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1401Cognitive Assessmentactive2017-05ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1402Cup to Disc Ratioactive2021-02ushl7loinc
us.nlm.vsacR42.16.840.1.113883.3.526.2.1403Optic Disc Exam for Structural Abnormalitiesactive2021-02ushl7loinc
us.nlm.vsacR42.16.840.1.113883.3.526.2.1509Acute and Subacute Iridocyclitisactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1521Burn Confined to Eye and Adnexaactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1523Burn Confined to Eye and Adnexaactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1524Cataract Secondary to Ocular Disordersactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1526Cataract Secondary to Ocular Disordersactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1527Cataract Surgeryactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1528Cataract Surgeryactive2025-01ushl7cpt
us.nlm.vsacR42.16.840.1.113883.3.526.2.1529Cataract Congenitalactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1530Cataract Congenitalactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1532Cataract Mature or Hypermatureactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1534Cataract Mature or Hypermatureactive2025-01ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1535Cataract Posterior Polaractive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1537Cataract Posterior Polaractive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1538Certain Types of Iridocyclitisactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1540Certain Types of Iridocyclitisactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1542Chronic Iridocyclitisactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1543Chronic Iridocyclitisactive2025-01ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1544Cloudy Corneaactive2021-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1546Cloudy Corneaactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1548Corneal Edemaactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1549Corneal Edemaactive2021-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1550Disorders of Cornea Including Corneal Opacityactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1552Disorders of Cornea Including Corneal Opacityactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1561Glaucomaactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1562Glaucomaactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1564Hereditary Corneal Dystrophiesactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1566Hereditary Corneal Dystrophiesactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1571Hypotony of Eyeactive2025-01ushl7sct